The GP-stake market — where institutional buyers acquire minority equity in fund management firms — has moved decisively from niche to mainstream over the last five years. Sovereign-adjacent platforms, dedicated GP-stakes funds, and the largest scaled family offices now allocate meaningful capital to this category, and the institutional ecosystem (counsel, advisory firms, valuation specialists) has built around the flow. The economics are different enough from traditional LP commitments to warrant a clear-eyed framework before any allocator commits.

The basic math runs through three levers. First, the fee-side participation: a GP-stake buyer typically receives a pro-rata share of the management fees the firm collects across all current and future funds. For a firm with $5B AUM and a 1.5% blended fee, that is $75M of annual fee revenue, and a 10% GP-stake purchaser earns $7.5M annually before the firm's operating costs. The earnings stream is durable so long as the firm continues to raise vintages, and it grows materially if the firm scales AUM, which is the typical thesis. Second, the carry-side participation: the GP-stake also entitles the buyer to a share of the carry (performance fee) generated across the firm's funds. This is the volatile component and the upside component, and across a multi-cycle hold can dwarf the fee-side returns. Third, the equity-value participation: GP stakes are typically purchased at a multiple of the firm's projected fee earnings (commonly 8–12x), and the buyer realises the equity-value uplift if the firm grows, sells to a strategic, or undergoes a partial liquidity event in a subsequent transaction.

The structural risks are equally specific. The first is key-person risk: GP stakes are bets on the senior partners, and the loss of one or two principal partners can materially impair the franchise. Buy-out provisions, lock-ups, and earnout structures address this but never fully eliminate it. The second is fundraising risk: a GP-stake's value depends on the firm raising successive vintages at scale; a fund that mis-steps at fundraise meaningfully impairs the GP-stake economics. The third is the liquidity risk: GP stakes are highly illiquid, with secondary markets still maturing, and the realised liquidity event is typically 7–15 years out.

For institutional buyers considering the category, the math works best when the manager is at scale (≥$3B AUM), has multi-vintage track record, and operates in a category where the secular tailwinds support continued AUM growth. Brillwood's Capital practice has structured several GP-stake transactions over the last 24 months. The category has matured. The discipline now is in distinguishing between the GP-stakes worth owning and the ones that are simply available.